Actively Recruiting

Phase 1
Age: 18Years - 64Years
All Genders
Healthy Volunteers
NCT06511947

Pharmacokinetics of GH001 Delivered Via a Proprietary Aerosol Delivery Device in Healthy Subjects

Led by GH Research Ireland Limited · Updated on 2024-08-07

52

Participants Needed

1

Research Sites

26 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The primary objectives of this trial are to determine the pharmacokinetic (PK) profile and the safety and tolerability of GH001 delivered via a proprietary aerosol delivery device in healthy subjects after single-dose administration and a single-day individualized dosing regimen (IDR). As secondary objectives, the mebufotenin PK/ pharmacodynamic (PD) relationship, the PD profile of GH001 as evaluated by its psychoactive effects (PsE), the impact on cognitive performance, and the TCmax/2 and TCmax/10 (time taken for Cmax to decrease by 50 and 90%, respectively) are also assessed.

CONDITIONS

Official Title

Pharmacokinetics of GH001 Delivered Via a Proprietary Aerosol Delivery Device in Healthy Subjects

Who Can Participate

Age: 18Years - 64Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Body mass index (BMI) in the range of 18.5 to 35 kg/m2 (inclusive) at screening
  • Good mental health in the opinion of the investigator
  • Normal spirometry (FEV1 of >80% of predicted and FVC of >80% of predicted value) at screening
Not Eligible

You will not qualify if you...

  • Known allergies or hypersensitivity to mebufotenin, bufotenin, melatonin, or triptans
  • Received any investigational medication or vaccine within 3 months prior to baseline or currently in follow-up for another trial
  • Current or past clinically significant condition making participation unsuitable per investigator judgment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

GH Research Clinical Trial Site

London, United Kingdom

Actively Recruiting

Loading map...

Research Team

G

GH Research Limited Clinical Trial Enquiries

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

6

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Pharmacokinetics of GH001 Delivered Via a Proprietary Aerosol Delivery Device in Healthy Subjects | DecenTrialz